Antioxidant treatment with carnitines is effective in infertile patients with prostatovesiculoepididymitis and elevated seminal leukocyte concentrations after treatment with nonsteroidal anti-inflammatory compounds

Fertility and Sterility

Volumn 78, Issue 6, 2002, Pages 1203-1208

  Vicari, Enzo ^a   La Vignera, Sandro ^a   Calogero, Aldo E ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Acetyl carnitine; Carnitine; Nonsteroidal anti inflammatory drugs; Prostatovesiculoepididymitis; Reactive oxygen species; Sperm variables

Indexed keywords

ANTIOXIDANT; CARNITINE; LEVACECARNINE; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; REACTIVE OXYGEN METABOLITE; SERRATIOPEPTIDASE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EPIDIDYMITIS; EVALUATION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; PREGNANCY RATE; PRIORITY JOURNAL; PROSTATOVESICULOEPIDIDYMITIS; RANDOMIZED CONTROLLED TRIAL; SEMEN ANALYSIS; SPERM; SPERMATOZOON DENSITY; SPERMATOZOON MOTILITY; TREATMENT OUTCOME;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; CARNITINE; EPIDIDYMITIS; FEMALE; GENITAL DISEASES, MALE; HUMANS; INFERTILITY, MALE; INFLAMMATION; LEUKOCYTES; MALE; PREGNANCY; PREGNANCY RATE; PROSPECTIVE STUDIES; PROSTATITIS; REACTIVE OXYGEN SPECIES; SEMEN; SEMINAL VESICLES;

EID: 0036905175     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)04350-9     Document Type: Article

References (33)

1. Vicari E. Seminal leukocyte concentration and related specific radical oxygen species production in different categories of patients with male accessory gland infection. Hum Reprod. 14:1999;2025-2030.
2. Vicari E. Effectiveness and limits of antimicrobial treatment on seminal leukocyte concentration and related reactive oxygen species production in patients with male accessory gland infection. Hum Reprod. 15:2000;2536-2544.
3. Arduini A. Carnitine and its acyl esters as secondary antioxidants? Am Heart J. 123:1992;1726-1727.
4. Vicari E., Calogero A.E. Effect of treatment with carnitines in patients with prostato-vesciculo-epididymitis. Hum Reprod. 16:2001;2338-2342.
5. Dousset B., Hussenet F. Cytokines in human semen. A new approach to male infertility. Press Med. 26:1997;24-29.
6. Hales D.B., Diemer T., Hales K.H. Role of cytokines in testicular function. Endocrine. 10:1999;201-217.
7. Potts R.J., Jefferies T.M., Notarianni L.J. Antioxidant capacity of the epididymis. Hum Reprod. 14:1999;2513-2516.
8. Omu A.E., al-Othman S., Mohamad A.S., al-Kaluwby N.M., Fernandes S. Antibiotic therapy for seminal infection. Effect on antioxidant activity and T-helper cytokines. J Reprod Med. 43:1998;855-864.
9. Zini A., Garrels K., Phang D. Antioxidant capacity in the semen of fertile and infertile men. Urology. 55:2000;922-926.
10. WHO manual for the standardized investigation and diagnosis of the infertile couple. 1993;Cambridge University Press, New York.
11. Laboratory manual for the examination of the human semen and sperm-cervical mucus interaction. 3rd ed:1992;Cambridge University Press, Cambridge (UK).
12. Aitken R.J., Clarkson J.S., Fishel S. Generation of reactive oxygen species, lipid peroxidation and human sperm function. Biol Reprod. 41:1989;183-197.
13. Shen H., Ong C. Detection of oxidative DNA damage in human sperm and its association with sperm function and male infertility. Free Radic Biol Med. 28:2000;529-536.
14. Aitken R.J., Irvine D.S., Wu F.C. Prospective analysis of sperm-oocyte fusion and reactive oxygen species generation as criteria for the diagnosis of infertility. Am J Obstet Gynecol. 164:1991;542-551.
15. Tarin J.J., Brines J., Cano A. Antioxidants may protect against infertility. Hum Reprod. 13:1998;1415-1416.
16. Ford W.C.L., Whittington K. Antioxidant treatment for male subfertility a promise that remains unfulfilled . Hum Reprod. 13:1998;1416-1419.
17. Lenzi A., Gandini L., Picardo M. A rationale for glutathione therapy. Hum Reprod. 13:1998;1419-1421.
18. Geva E., Lessing J.B., Lerner-Geva L., Amit A. Free radicals, antioxidants and human spermatozoa clinical implications . Hum Reprod. 13:1998;1422-1424.
19. Moncada M.L., Vicari E., Cimino C., Calogero A.E., Mongioí A., D'Agata R. Effect of acetylcarnitine treatment in oligoasthenospermic patients. Acta Eur Fertil. 23:1992;221-224.
20. Lenzi A., Culasso F., Gandini L., Lombardo F., Dondero F. Placebo-controlled, double-blind, cross-over trial of glutathione therapy in male infertility. Hum Reprod. 8:1993;1657-1662.
21. Costa M., Canale D., Filicori M., D'Iddio S., Lenzi A. L-Carnitine in idiopathic asthenozoospermia a multicenter study . Andrologia. 26:1994;155-159.
22. Vitali G., Parente R., Melotti C. Carnitine supplementation in human idiopathic asthenospermia clinical results . Drugs Exp Clin Res. 21:1995;157-159.
23. Kessopoulou E., Powers H.J., Sharma K.K., Pearson M.J., Russell J.M., Cooke I.D., et al. A double-blind randomized placebo cross-over controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility. Fertil Steril. 64:1995;825-831.
24. Sikka S.C., Rajasekaran M., Hellstrom W.J.G. Role of oxidative stress and antioxidants in male fertility. J Androl. 16:1995;464-468.
25. Comhaire F.H., Mahmoud A.M., Depuydt C.E., Zalata A.A., Christophe A.B. Mechanisms and effects of male genital tract infection on semen quality and fertilizing potential the andrologist's viewpoint . Hum Reprod Update. 5:1999;393-398.
26. Comhaire F.H., Christophe A.B., Zalata A.A., Dhooge W.S., Mahmoud A.M., Depuydt C.E. The effects of combined conventional treatment, oral antioxidants and essential fatty acids on sperm biology in subfertile men. Prostaglandins Leukot Essent Fatty Acids. 63:2000;159-165.
27. Depuydt C.E., Bosmans E., Zalata A., Schoonjans F., Comhaire F.H. The relation between reactive oxygen species and cytokines in andrological patients with or without male accessory gland infection. J Andrology. 17:1996;699-707.
28. Wilton L.J., Temple-Smith P.D., Baker H.W., de Kretser D.M. Human male infertility caused by degeneration and death of sperm in the epididymis. Fertil Steril. 49:1988;1052-1058.
29. Ochsendorf F.R. Infections in the male genital tract and reactive oxygen species. Hum Reprod Update. 5:1999;399-420.
30. Johnson L., Varver D.D. Effect of daily sperm production but not age on transit time of spermatozoa through the human epididymis. Biol Reprod. 39:1998;812-817.
31. Jeulin C., Lewin L.M. Role of free L-carnitine and acetyl-L-carnitine in post-gonadal maturation of mammalian spermatozoa. Hum Reprod Update. 2:1996;87-102.
32. O'Donovan P.A., Vandekerchhove P., Lilford R.J., Hughes E. Treatment of male infertility: is it effective? Review and meta-analyses of published randomised controlled trials. Hum Reprod. 8:1993;1209-1222.
33. Schill W.B. Survey of medical therapy in andrology. Int J Androl. 18:1995;56-62.